Emtricitabine rilpivirine tenofovir adverse reactions

Revision as of 05:03, 10 January 2014 by Mohamed Moubarak (talk | contribs) (Created page with "==Adverse Reactions== ADVERSE REACTIONS The following adverse drug reactions are discussed in other sections of the labeling: * Lactic Acidosis/Severe Hepatomegaly with Stea...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Adverse Reactions

ADVERSE REACTIONS

The following adverse drug reactions are discussed in other sections of the labeling:

  • Lactic Acidosis/Severe Hepatomegaly with Steatosis [See Boxed Warning, Warnings and Precautions].
  • Severe Acute Exacerbations of Hepatitis B [See Boxed Warning, Warnings and Precautions].
  • New Onset or Worsening Renal Impairment [See Warnings and Precautions].
  • Depressive Disorders [See Warnings and Precautions].
  • Hepatotoxicity [See Warnings and Precautions].
  • Bone Effects of Tenofovir DF [See Warnings and Precautions].
  • Immune Reconstitution Syndrome [See Warnings and Precautions].[1]

References

  1. "COMPLERA (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE) TABLET, FILM COATED [GILEAD SCIENCES, INC.]". Text " accessdate" ignored (help)

Adapted from the FDA Package Insert.